OasisLMS

Controversies in NSCLC OMD

Opening Ceremony

New Questinos with Imaginative Answers

Presidential Symposium Including Top 7 Rated Abstracts

Relevant Aspects of Lung Cancer Management

Food for Thought in the Management of Thoracic Malignancies

Joint IASLC-CSCO-CAALC Session

What Is the Role of Chemotherapy in the Era of Immunotherapy in Advanced NSCLC?

Management of Oncogene Addicted Patients with Stage III NSCLC

BAP-1 and Other Novel Molecular and Metabolic Targets in Mesothelioma

Multimodality Management of Small Cell and Neuroendocrine Cancers

Joint Session GLCC/IASLC: Hot Topics for Lung Cancer Advocates

New Approaches in Second Line Treatment In NSCLC

Thoracic Ultrasonography: Diagnosis and Staging

Critical Concerns in Screening

How I Do It - Real World Issues in the Diagnosis and Treatment of Metastatic NSCLC

Oncology Drug Approval: Challenges and Opportunities

Lung Cancer Plasticity and Drug Resistance

Lung Cancer Pathology in the Age of Genomics

Global Political, Legal, and Financial Strategies For Tobacco Control

What First Line in Oncogene Addicted NSCLC

The Management of Cancer Treatment in Thoracic Malignancy

Modern Radiotherapy in Stage III NSCLC

Molecular Alterations and Heterogeneity in Mesothelioma

Acquired Resistance to TKIs: The Rebiopsy Case and the Future Options

Recently Diagnosed Malignant Pleural Effusion

Strategies for Cancer Patients to Have Optimal Outcomes

Current Strategies to Improve Outcome of Patients with Oligometastatic NSCLC

Immunotherapy - Discovering New Areas

Optimal Management of N2 Disease in the Era Of IO

Diagnosis and Management of Side Effects of Immunotherapy

Liquid Biopsy

The Impact of Specialist Nursing and Allied Health Professionals in the Care of Thoracic Oncology Patients

Whether and How to Adapt Treatment of NSCLC Oligometastatic Disease to . . .

Improving Patients Quality of Life During Treatment of Metastatic Disease

Problem Areas for the Next WHO Classification of Lung Cancers

My Oligometastatic Oncogene Driven Patient

Making Sense of Treatment with so Many Options: My Algorithm

Personalized Management of Elderly Patients with Stage III NSCLC

Hyperprogressive Disease

Lung Cancer Genetics to Beat Lung Cancer

Multimodality Treatment - Realtime Data from National Registries

Enhancing Recovery in the Treatment of Thoracic Malignancy

Role of Pathologist in the Era of Immunotherapies

Challenges in Translating Small Cell and Neuroendocrine Tumor Research into Clinical Practice

Tracheal Tumours

Electronic Cigarettes and Heat-Not-Burn Tobacco Products - How Are They Different

Case-Based Management of Brain Metastatsis (BM) in Advanced Lung Cancer Patients: Changing the Standards

How to Identify and Manage Toxicity in Stage III

Best Management of Early Stage NSCLC in ILD Patients

Biology and Genetics in ICI Treatments

Invasive Diagnosis and Surgery in Lung Cancer Screening Participants

Undertaking Nursing and Allied Health Research - How to Survive It and Get Published

Essentials in Biomarker Testing for Lung Cancer

Novel Approaches in Radiation Oncology for Small Cell Lung Cancer and Neuroendocrine Cancers

Endoscopic Solution to Iatrogenic Complications (Interactive Q&A)

Combating Toxicity of IO-Chemotherapy Combinations

JTO Workshop: How to Get Your Manuscript Published

Treatment of NSCLC OMB in Clinical Practice

Optimal Immunotherapy Sequence in Stage IV NSCLC

Optimal GGO Management

Treatment Techniques for Localized Therapy in Malignant Pleural Mesothelioma

Chestwall Tumors

Managing Side Effects for Better Quality of Life

How to Successfully Run a Multiodisciplinary Tumor Board

Risk Assessment in CT Screening

Trial Design and Novel Drug Accessibility

First Time Attendee Session

Clinical Trials

Scientific Mentoring

Basics of Immunology

Oligometastatic Disease

MA02.

Clinomics and Genomics

MA04.

Update on Clinical Trials and Treatments

Challenges in the Treatmetn of Early Stage NSCLC

Clinical Questions and Potential Blood Markers for Immunotherapy

Paving the Way to Improve Outcomes in Stage III NSCLC

EGFR & MET

Emerging Technologies for Lung Cancer Detection

Immunotherapy in Special Populations and Predictive Markers

New Frontiers from Pathology to Genomics

Going Back to the Roots!

The Adequate MTarget is Still the Issue

Usage of Computer and Molecular Analysis in Treatment Selection and Disease Prognostication

Prioritizing Use of Technology to Improve Survival of Lung Cancer Subgroups and Outcomes with Chemotherapy and Surgery

Molecular Mechanisms and Therapies

Advances in Diagnosis of Common Types of NSCLC

Looking at Pros in Greater Detail - What Patients Actually Want and Expect

Thymic Tumors: From Molecular to Clinical Results and New Challenges in Other Rare Thoracic Tumors

Non EGFR/MET Targeted Therapies

Partnering with Patients to Understand Stigma, Disparities and Values Leading to Improved Lung Cancer Care

Preclinical Models and Genetics of Malignant Pleural Mesothelioma

Initiatives to Improve Health in Lung Cancer Patients

Precision Medicine in Advanced NSCLC

Immunotherapy Resistance

What Molecular Screening for Which Patients?

Workup and Management of Small Anterior Mediastinal Masses/Lesions

New Systemic Adjuvant/Neo-adjuvant Strategies in Early Stage Lung Cancer: Targeted Therapy and I/O

Novel Biological Pathways and Druggable Targets

An Interdisciplinary Approach to Optimal Nodal Staging

Controversies with Stereotactic Radiation in Early Stage Lung Cancer

Management of Thymic Carcinoma

Immunotherapy in Small Cell Lung Cancer

Lung Cancer Screening, Opportunistic Evaluation of Findings

Addressing Challenges with Surgical Resection of Lung Cancer

Genome Screenings

Immunotherapy for Mesothelioma

Molecular Subsets and Novel Targeted Approaches to Small Cell and Neuroendocrine Cancers

How to Get Patients to Quit Smoking; Practical Implementation of Evidence-Based Cessation Practices

The Interventional Pulmonologist's Contribution to Screen-Detected Nodules: From Diagnosis to Treatment

Pathology of the Future

Role of Biomarkers in Lung Cancer Screening

Advanced Diagnostic Approaches for Intrathoracic Lymph Nodes and Peripheral Lung Tumors

A New Vision of Targets and Strategies

Stystemic Therapies for SCLC: Novel Targets and Patients' Selection

Immuno Combinations and the Role of TMB

Increasing the Impact of Nursing and Allied Health Professional Interventions in Lung Cancer Care

Refining Lung Cancer Screening

Precision Medicine Involves Biology and Patients

Advanced Models and "Omics" for Therapeutic Development

Lung Cancer: A Preventable Disease?

Sophisticated TNM Staging System for Lung Cancer

Decomplexifying Molecular Targets, Immunotherapy and Treatment Setting in the Real World

Profiling the Multidisciplinary Management of Stage III NSCLC

Ideal Approach to Lung Resection and Novel Perioperative Therapy

Update of Phase 3 Trials and the Role of HPD

Targeted Therapy and Immunotherapy for Small Cell Lung Cancer

Reinventing Clinical Trials

Combining with Chemo: Old School is New Again

Adjuvant Therapy for Resected NSCLC Harboring EGFR Mutation, Chemotherapy or Targeted Therapy

Is Chemotherapy Necessary for Advanced NSCLC Patients with PD-L1 50% or More?

Immune Checkpoint Inhibitors in Real World - How Do We Treat NSCLC "Special Populations"

Highlight of the Previous Day

Highlights of the Previous Day

IASLC CT Screening Symposium: Forefront Advances in Lung Cancer Screening

Symposium Honoring Dr. Gazdar's Legacy

Cancer Genomics Workshop

Mesothelioma Workshop

ITONF Workshop: Bridging the Gaps in Thoracic Oncology Nursing - A Global Perspective

Staing Workshop Part 1: IASLC Database Challenges and Application

Staging Workshop Part 2: The Importance of Invasive Modal Staging in Thoracic Malignancies

Women in Thoracic Oncology Networking Event